Palomino Laboratories (PALX) Accounts Payables (2022 - 2025)

Palomino Laboratories (PALX) reported Accounts Payables of $55687.0 for Q4 2025, up 1592.1% on a YoY basis from $3291.0 in Q4 2024, and down 8.64% sequentially from $60952.0 in Q3 2025.

Palomino Laboratories (PALX) Accounts Payables (2022 - 2025) Analysis & Trends

Palomino Laboratories (PALX) has 4 years of Accounts Payables data on file, last reported at $55687.0 in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 1592.1% year-over-year to $55687.0; the trailing twelve-month figure through Dec 2025 stood at $55687.0 (up 1592.1% YoY), and the FY2025 full-year result was $55687.0, up 1592.1% from the prior year.
  • Accounts Payables declined to $55687.0 in Q4 2025, from $60952.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $60952.0 in Q3 2025 to a low of $58.0 in Q4 2023.
  • A 4-year average of $35037.1 and a median of $43954.0 in 2024 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables slumped 99.54% in 2023 and jumped 5574.14% in 2024, its largest moves.
  • Tracing PALX's Accounts Payables over 4 years: stood at $12500.0 in 2022, then tumbled by 99.54% to $58.0 in 2023, then jumped by 5574.14% to $3291.0 in 2024, then jumped by 1592.1% to $55687.0 in 2025.
  • Business Quant data shows PALX's Accounts Payables at $55687.0 in Q4 2025, $60952.0 in Q3 2025, and $40781.0 in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 55,687.00
Sep 30, 2025 60,952.00
Jun 30, 2025 40,781.00
Mar 31, 2025 45,816.00
Dec 31, 2024 3,291.00
Sep 30, 2024 46,757.00
Jun 30, 2024 43,954.00
Mar 31, 2024 47,112.00
Dec 31, 2023 58.00
Sep 30, 2023 28,500.00
Dec 31, 2022 12,500.00